. "3"^^ . "Possibilities to increase the effectiveness of doxorubicin in cancer cells killing"@en . "0360-2532" . "3"^^ . "US - Spojen\u00E9 st\u00E1ty americk\u00E9" . "4" . . . . "A searching for some possibilities how to increase DOX efficacy in cancer cells and minimizing associated toxicities to non-cancerous tissues is in the forefront of scientific research. This review brings an overview of various approaches and a summary of their principles. Possible advantages, disadvantages and further perspectives are discussed and evaluated."@en . . . "Bou\u0161ov\u00E1, Iva" . "43" . "RIV/00216208:11160/11:10100467" . . "A searching for some possibilities how to increase DOX efficacy in cancer cells and minimizing associated toxicities to non-cancerous tissues is in the forefront of scientific research. This review brings an overview of various approaches and a summary of their principles. Possible advantages, disadvantages and further perspectives are discussed and evaluated." . "http://informahealthcare.com/doi/pdf/10.3109/03602532.2011.609174" . . . "Possibilities to increase the effectiveness of doxorubicin in cancer cells killing" . . . "000296092500007" . . . "Possibilities to increase the effectiveness of doxorubicin in cancer cells killing" . . . . "11160" . "221793" . . "18"^^ . "Sk\u00E1lov\u00E1, Lenka" . "oxidative stress; doxorubicin deactivation; resistance; efflux transporters; doxorubicin conjugation"@en . "10.3109/03602532.2011.609174" . "RIV/00216208:11160/11:10100467!RIV12-GA0-11160___" . . "Possibilities to increase the effectiveness of doxorubicin in cancer cells killing"@en . . "Drug Metabolism Reviews" . "Hanu\u0161ov\u00E1, Veronika" . "[28DF5E4FFDFF]" . . "P(GP524/09/P121), S" . .